Matches in SemOpenAlex for { <https://semopenalex.org/work/W3168971294> ?p ?o ?g. }
Showing items 1 to 83 of
83
with 100 items per page.
- W3168971294 endingPage "81" @default.
- W3168971294 startingPage "78" @default.
- W3168971294 abstract "An unmet clinical need currently exists for elderly patients with relapsed/resistant (R/R) Philadelphia (Ph) positive acute lymphoblastic leukemia (ALL), nearly all who have a very poor prognosis. This includes patients already exposed to the first or second generation tyrosine kinase inhibitors (TKIs) and therefore has few treatment options available. New immunotherapies and targeted agents have shown encouraging activity in R/R ALL irrespective of age. Inotuzumab (InO), a humanized anti-CD22 monoclonal antibody, has potentially beneficial clinical effects in patients with resistant and difficult-to-treat disease in whom prior TKIs have failed. However, InO, as a single agent, did not show durable response and longer progression free survival and overall survival in R/R Ph positive ALL patients compared with those treated with standard chemotherapy. We observed a durable molecular remission (7 months) in an elderly patient affected by Ph'+ ALL with T315I and concomitant p190 and p210 expression achieved by concomitant therapy of InO (for 4 cycles) and ponatinib (15 mg/daily) followed by ponatinib (15 mg/daily) only as maintenance therapy. These findings suggest that elderly R/R Ph positive patients who cannot proceed to the transplant might benefit by concomitant immunotherapy and TKIs aimed to deepen the responses and prolong CR and outcomes." @default.
- W3168971294 created "2021-06-22" @default.
- W3168971294 creator A5001627727 @default.
- W3168971294 creator A5010335217 @default.
- W3168971294 creator A5051164378 @default.
- W3168971294 creator A5054876863 @default.
- W3168971294 creator A5067350210 @default.
- W3168971294 creator A5089717138 @default.
- W3168971294 date "2021-01-01" @default.
- W3168971294 modified "2023-09-26" @default.
- W3168971294 title "Durable Molecular Remission in an Elderly Patient Affected by Relapsed Ph'+ Acute Lymphoblastic Leukemia with T315I and Concomitant p190 and p210 Expression Achieved by Inotuzumab and Ponatinib" @default.
- W3168971294 cites W1488000644 @default.
- W3168971294 cites W2065851457 @default.
- W3168971294 cites W2147109509 @default.
- W3168971294 cites W2344488712 @default.
- W3168971294 cites W2785037227 @default.
- W3168971294 cites W2790768260 @default.
- W3168971294 doi "https://doi.org/10.1159/000516593" @default.
- W3168971294 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34102636" @default.
- W3168971294 hasPublicationYear "2021" @default.
- W3168971294 type Work @default.
- W3168971294 sameAs 3168971294 @default.
- W3168971294 citedByCount "0" @default.
- W3168971294 crossrefType "journal-article" @default.
- W3168971294 hasAuthorship W3168971294A5001627727 @default.
- W3168971294 hasAuthorship W3168971294A5010335217 @default.
- W3168971294 hasAuthorship W3168971294A5051164378 @default.
- W3168971294 hasAuthorship W3168971294A5054876863 @default.
- W3168971294 hasAuthorship W3168971294A5067350210 @default.
- W3168971294 hasAuthorship W3168971294A5089717138 @default.
- W3168971294 hasConcept C121608353 @default.
- W3168971294 hasConcept C126322002 @default.
- W3168971294 hasConcept C143998085 @default.
- W3168971294 hasConcept C203014093 @default.
- W3168971294 hasConcept C2776694085 @default.
- W3168971294 hasConcept C2777583451 @default.
- W3168971294 hasConcept C2777701055 @default.
- W3168971294 hasConcept C2778020697 @default.
- W3168971294 hasConcept C2778283404 @default.
- W3168971294 hasConcept C2778461978 @default.
- W3168971294 hasConcept C2778729363 @default.
- W3168971294 hasConcept C2779384505 @default.
- W3168971294 hasConcept C2779536868 @default.
- W3168971294 hasConcept C2780381907 @default.
- W3168971294 hasConcept C2909962599 @default.
- W3168971294 hasConcept C71924100 @default.
- W3168971294 hasConceptScore W3168971294C121608353 @default.
- W3168971294 hasConceptScore W3168971294C126322002 @default.
- W3168971294 hasConceptScore W3168971294C143998085 @default.
- W3168971294 hasConceptScore W3168971294C203014093 @default.
- W3168971294 hasConceptScore W3168971294C2776694085 @default.
- W3168971294 hasConceptScore W3168971294C2777583451 @default.
- W3168971294 hasConceptScore W3168971294C2777701055 @default.
- W3168971294 hasConceptScore W3168971294C2778020697 @default.
- W3168971294 hasConceptScore W3168971294C2778283404 @default.
- W3168971294 hasConceptScore W3168971294C2778461978 @default.
- W3168971294 hasConceptScore W3168971294C2778729363 @default.
- W3168971294 hasConceptScore W3168971294C2779384505 @default.
- W3168971294 hasConceptScore W3168971294C2779536868 @default.
- W3168971294 hasConceptScore W3168971294C2780381907 @default.
- W3168971294 hasConceptScore W3168971294C2909962599 @default.
- W3168971294 hasConceptScore W3168971294C71924100 @default.
- W3168971294 hasIssue "3" @default.
- W3168971294 hasLocation W31689712941 @default.
- W3168971294 hasOpenAccess W3168971294 @default.
- W3168971294 hasPrimaryLocation W31689712941 @default.
- W3168971294 hasRelatedWork W2593332867 @default.
- W3168971294 hasRelatedWork W3093938683 @default.
- W3168971294 hasRelatedWork W3134845669 @default.
- W3168971294 hasRelatedWork W3168971294 @default.
- W3168971294 hasRelatedWork W3214726543 @default.
- W3168971294 hasRelatedWork W3215637673 @default.
- W3168971294 hasRelatedWork W4286512586 @default.
- W3168971294 hasRelatedWork W4296532741 @default.
- W3168971294 hasRelatedWork W4311669151 @default.
- W3168971294 hasRelatedWork W4366779597 @default.
- W3168971294 hasVolume "66" @default.
- W3168971294 isParatext "false" @default.
- W3168971294 isRetracted "false" @default.
- W3168971294 magId "3168971294" @default.
- W3168971294 workType "article" @default.